Accueil   Diary - News   All news Adocia Initiates Phase 2 Clinical Trial

Adocia Initiates Phase 2 Clinical Trial

 

Adocia Initiates Phase 2 Clinical Trial for M1Pram in Patients with Type 1 Diabetes

 

 

  • Phase 2 study evaluates safety and efficacy of M1Pram, assessing weight loss in overweight and obese T1D patients as well as improved HbA1c
  • The study has been designed to define parameters for the upcoming Phase 3 trial planned for 2022
  • This study follows the promising results of the proof-of-concept Phase 1 trial announced on September 15, 2020

 

 

Read the press release